{"transactions":[{"id":717698,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-07-02T20:16:44.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":36818,"price":0.1921,"value":7072.7378,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended (the \"ESPP\"), in a transaction exempt under Rule 16b-3 and Rule 16b-3(d). The Reporting Person purchased the maximum amount permitted under the ESPP."}],"balance_after":54846,"source":{"system":"sec-edgar","filing":"0001412071-26-000006","document":"form4-07022026_080729.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141207126000006/form4-07022026_080729.xml","form_type":"4"}},{"id":811405,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-04-10T00:41:53.000Z","date":"2026-04-07","kind":"grant","planned":false,"acquired":true,"shares":71268,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options (the \"Options\") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. 25% of the Options will vest on the six-month anniversary of April 7, 2026 (the \"Grant Date\"), and will vest in 25% installments every six months thereafter until the Options become fully vested on the two (2) year anniversary of the Grant Date."}],"balance_after":71268,"derivative":{"exercise_price":0.5358,"expiration_date":"2036-04-07","underlying":"Common Stock","underlying_shares":71268},"source":{"system":"sec-edgar","filing":"0001412071-26-000004","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141207126000004/edgardoc.xml","form_type":"4"}},{"id":811404,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2026-04-10T00:41:53.000Z","date":"2026-04-07","kind":"grant","planned":false,"acquired":true,"shares":3732,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options (the \"Options\") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. 25% of the Options will vest on the six-month anniversary of April 7, 2026 (the \"Grant Date\"), and will vest in 25% installments every six months thereafter until the Options become fully vested on the two (2) year anniversary of the Grant Date."}],"balance_after":3732,"derivative":{"exercise_price":0.5358,"expiration_date":"2036-04-07","underlying":"Common Stock","underlying_shares":3732},"source":{"system":"sec-edgar","filing":"0001412071-26-000004","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141207126000004/edgardoc.xml","form_type":"4"}},{"id":1097739,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-07-01T21:48:28.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":7541,"price":1.7,"value":12819.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d)."}],"balance_after":18028,"source":{"system":"sec-edgar","filing":"0001415889-25-018748","document":"form4-07012025_090724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588925018748/form4-07012025_090724.xml","form_type":"4"}},{"id":1101628,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-25T21:15:06.000Z","date":"2025-06-23","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options (the \"Options\") granted pursuant to the Issuer's Amended and Restated 2019 Equity Omnibus Incentive Plan, as amended. The Options will begin vesting on June 23, 2025 (the \"Grant Date\"), and will vest in equal monthly installments over a three-year period until the Options become fully vested on the three (3) year anniversary of the Grant Date."}],"balance_after":300000,"derivative":{"exercise_price":1.96,"expiration_date":"2035-06-23","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001415889-25-018200","document":"form4-06252025_050601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588925018200/form4-06252025_050601.xml","form_type":"4"}},{"id":1462619,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-07-02T22:06:41.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":4854,"price":2.958,"value":14358.132,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan, as amended."}],"balance_after":10487,"source":{"system":"sec-edgar","filing":"0001415889-24-019020","document":"form4-07022024_100738.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588924019020/form4-07022024_100738.xml","form_type":"4"}},{"id":1468674,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-27T01:31:44.000Z","date":"2024-06-24","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options (the \"Options\") granted pursuant to the Issuer's Amended and Restated 2019 Equity Omnibus Incentive Plan, as amended. The Options will begin vesting on June 24, 2024 (the \"Vesting Start Date\"), and will vest in equal monthly installments over a three-year period until the Options become fully vested on the three (3) year anniversary of the Vesting Start Date."}],"balance_after":500000,"derivative":{"exercise_price":3.23,"expiration_date":"2034-06-24","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001415889-24-018279","document":"form4-06272024_010639.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588924018279/form4-06272024_010639.xml","form_type":"4"}},{"id":1691730,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-01-03T22:17:08.000Z","date":"2023-12-29","kind":"grant","planned":false,"acquired":true,"shares":167,"price":1.717,"value":286.739,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased pursuant to the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan."}],"balance_after":5633,"source":{"system":"sec-edgar","filing":"0001415889-24-000344","document":"form4-01032024_100142.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588924000344/form4-01032024_100142.xml","form_type":"4"}},{"id":1835752,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2023-07-05T20:05:17.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":167,"price":1.5895,"value":265.4465,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan (\"ESPP\")."}],"balance_after":5466,"source":{"system":"sec-edgar","filing":"0001415889-23-010721","document":"form4-07052023_040705.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588923010721/form4-07052023_040705.xml","form_type":"4"}},{"id":2072474,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2023-01-03T21:10:52.000Z","date":"2022-12-30","kind":"grant","acquired":true,"shares":5000,"price":0.0876,"value":438.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan (\"ESPP\")."}],"balance_after":158998,"source":{"system":"sec-edgar","filing":"0001415889-23-000041","document":"form4-01032023_090116.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588923000041/form4-01032023_090116.xml","form_type":"4"}},{"id":2179434,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2022-08-18T19:56:47.000Z","date":"2022-08-17","kind":"purchase","acquired":true,"shares":600000,"price":0.172,"value":103200.0,"ownership":{"direct":false,"nature":"By The 1997 Singh Family Trust U/R/D 05/29/97"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.1600 to $0.1975, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":626234,"source":{"system":"sec-edgar","filing":"0001415889-22-008814","document":"form4-08182022_120836.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588922008814/form4-08182022_120836.xml","form_type":"4"}},{"id":2206880,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2022-07-15T20:30:29.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":5000,"price":0.748,"value":3740.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares purchased under the VistaGen Therapeutics, Inc. 2019 Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c)"}],"balance_after":153998,"source":{"system":"sec-edgar","filing":"0001415889-22-007688","document":"form4-07152022_040717.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588922007688/form4-07152022_040717.xml","form_type":"4"}},{"id":2270176,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-16T17:39:31.000Z","date":"2022-05-12","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option vested 25% on the grant date of September 5, 2019, with the remainder vesting monthly over the 36 months thereafter."}],"balance_after":70000,"derivative":{"exercise_price":1,"expiration_date":"2029-09-05","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-22-004988","document":"form4-05162022_100519.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588922004988/form4-05162022_100519.xml","form_type":"4"}},{"id":2270175,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2022-05-16T17:39:31.000Z","date":"2022-05-12","kind":"exercise","acquired":true,"shares":100000,"price":1,"value":100000.0,"ownership":{"direct":true},"balance_after":148998,"source":{"system":"sec-edgar","filing":"0001415889-22-004988","document":"form4-05162022_100519.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588922004988/form4-05162022_100519.xml","form_type":"4"}},{"id":2353768,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-03T21:14:29.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan.  Twenty-five percent (25%) of the total number of shares vest immediately on March 1, 2022 (the \"Vesting Start Date\") and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested two (2) years after the Vesting Start Date."}],"balance_after":300000,"derivative":{"exercise_price":1.37,"expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001415889-22-002294","document":"form4-03032022_010311.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588922002294/form4-03032022_010311.xml","form_type":"4"}},{"id":2454104,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2022-01-03T21:17:51.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":3623,"price":1.6575,"value":6005.1225,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased under the VistaGen Therapeutics, Inc. 2019 Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c)"}],"balance_after":48998,"source":{"system":"sec-edgar","filing":"0001415889-22-000034","document":"form4-01032022_010137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588922000034/form4-01032022_010137.xml","form_type":"4"}},{"id":2644258,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2021-07-02T20:10:40.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":5000,"price":1.9465,"value":9732.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan on June 30, 2021 in a transaction exempt under Rule 16b-3(c)."}],"balance_after":45375,"source":{"system":"sec-edgar","filing":"0001415889-21-003387","document":"form4-07022021_040701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588921003387/form4-07022021_040701.xml","form_type":"4"}},{"id":2738385,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-27T20:13:40.000Z","date":"2021-04-23","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.5,"exercise_date":"2018-08-29","expiration_date":"2021-04-26","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001415889-21-002139","document":"form4-04272021_010440.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588921002139/form4-04272021_010440.xml","form_type":"4"}},{"id":2738384,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2021-04-27T20:13:40.000Z","date":"2021-04-23","kind":"exercise","acquired":true,"shares":5000,"price":1.5,"value":7500.0,"ownership":{"direct":true},"balance_after":40375,"source":{"system":"sec-edgar","filing":"0001415889-21-002139","document":"form4-04272021_010440.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588921002139/form4-04272021_010440.xml","form_type":"4"}},{"id":2925402,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-04T21:58:40.000Z","date":"2020-12-30","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent (25%) of the total number of shares shall be vested immediately on December 31, 2020 (the \"Vesting Start Date\") and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested two (2) years after the Vesting Start Date."}],"balance_after":300000,"derivative":{"exercise_price":1.77,"expiration_date":"2030-12-30","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001415889-21-000020","document":"form4-01042021_010131.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588921000020/form4-01042021_010131.xml","form_type":"4"}},{"id":2925401,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2021-01-04T21:58:40.000Z","date":"2020-12-31","kind":"grant","acquired":true,"shares":5000,"price":0.4521,"value":2260.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan on December 31, 2020 in a transaction exempt under Rule 16b-3(c)."}],"balance_after":35375,"source":{"system":"sec-edgar","filing":"0001415889-21-000020","document":"form4-01042021_010131.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588921000020/form4-01042021_010131.xml","form_type":"4"}},{"id":3095088,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2020-07-01T21:20:06.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":5000,"price":0.448,"value":2240.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan (\"ESPP\") on June 30, 2020."}],"balance_after":30375,"source":{"system":"sec-edgar","filing":"0001415889-20-001764","document":"form4-07012020_020757.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588920001764/form4-07012020_020757.xml","form_type":"4"}},{"id":3169004,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-27T21:10:39.000Z","date":"2020-04-23","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the total number of shares shall be vested immediately on April 23, 2020 (the \"Vesting Start Date\") and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested two (2) years after the Vesting Start Date."}],"balance_after":300000,"derivative":{"exercise_price":0.398,"expiration_date":"2030-04-23","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001415889-20-001064","document":"form4-04272020_050423.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588920001064/form4-04272020_050423.xml","form_type":"4"}},{"id":3389708,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-22T21:01:22.000Z","date":"2019-10-21","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the Shares subject to the Option shall vest on date of grant October 21, 2019, and 1/24th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the grant date thereafter."}],"balance_after":300000,"derivative":{"exercise_price":1.41,"expiration_date":"2029-10-21","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001415889-19-001211","document":"form4-10222019_051000.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588919001211/form4-10222019_051000.xml","form_type":"4"}},{"id":3510182,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-28T20:07:55.000Z","date":"2019-05-28","kind":"grant","acquired":true,"shares":170000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option granted under the Issuer's 2019 Omnibus Equity Incentive Plan (the \"2019 Plan\"), which was approved by the Issuer's Board of Directors on May 27, 2019, subject to the approval of the 2019 Plan by the Issuer's stockholders. The Option will not begin vesting until the 2019 Plan is approved by the Issuer's stockholders, at which time 25% of the Option will vest and the remainder will vest ratably in monthly installments over the following 36 months. In no event will the Option be exercisable prior to approval of the 2019 Plan by the Issuer's stockholders."}],"balance_after":170000,"derivative":{"exercise_price":1,"expiration_date":"2029-05-28","underlying":"Common Stock","underlying_shares":170000},"source":{"system":"sec-edgar","filing":"0001415889-19-000581","document":"form4-05282019_010542.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588919000581/form4-05282019_010542.xml","form_type":"4"}},{"id":3510181,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-28T20:07:55.000Z","date":"2019-05-23","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted under the Issuer's Amended and Restated 2016 Stock Incentive Plan, as amended. 50,000 of the shares subject to the Option will vest on the Vesting Start Date of May 23, 2019, and 1/36th of the remaining shares subject to the Option will vest on each monthly anniversary of the Vesting Start Date thereafter."}],"balance_after":80000,"derivative":{"exercise_price":1,"expiration_date":"2029-05-23","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001415889-19-000581","document":"form4-05282019_010542.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588919000581/form4-05282019_010542.xml","form_type":"4"}},{"id":3695553,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-15T21:29:36.000Z","date":"2019-01-14","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.5,"exercise_date":"2018-08-29","expiration_date":"2019-03-24","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001415889-19-000055","document":"form4-01152019_010122.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588919000055/form4-01152019_010122.xml","form_type":"4"}},{"id":3695552,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-15T21:29:36.000Z","date":"2019-01-14","kind":"exercise","acquired":false,"shares":1125,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.5,"exercise_date":"2018-08-28","expiration_date":"2019-06-17","underlying":"Common Stock","underlying_shares":1125},"source":{"system":"sec-edgar","filing":"0001415889-19-000055","document":"form4-01152019_010122.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588919000055/form4-01152019_010122.xml","form_type":"4"}},{"id":3695551,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-15T21:29:36.000Z","date":"2019-01-14","kind":"exercise","acquired":false,"shares":21250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.5,"exercise_date":"2018-08-29","expiration_date":"2019-12-31","underlying":"Common Stock","underlying_shares":21250},"source":{"system":"sec-edgar","filing":"0001415889-19-000055","document":"form4-01152019_010122.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588919000055/form4-01152019_010122.xml","form_type":"4"}},{"id":3695550,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2019-01-15T21:29:36.000Z","date":"2019-01-14","kind":"exercise","acquired":true,"shares":3000,"price":1.5,"value":4500.0,"ownership":{"direct":true},"balance_after":25375,"source":{"system":"sec-edgar","filing":"0001415889-19-000055","document":"form4-01152019_010122.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588919000055/form4-01152019_010122.xml","form_type":"4"}},{"id":3695549,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2019-01-15T21:29:36.000Z","date":"2019-01-14","kind":"exercise","acquired":true,"shares":1125,"price":1.5,"value":1687.5,"ownership":{"direct":true},"balance_after":22375,"source":{"system":"sec-edgar","filing":"0001415889-19-000055","document":"form4-01152019_010122.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588919000055/form4-01152019_010122.xml","form_type":"4"}},{"id":3695548,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2019-01-15T21:29:36.000Z","date":"2019-01-14","kind":"exercise","acquired":true,"shares":21250,"price":1.5,"value":31875.0,"ownership":{"direct":true},"balance_after":21250,"source":{"system":"sec-edgar","filing":"0001415889-19-000055","document":"form4-01152019_010122.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588919000055/form4-01152019_010122.xml","form_type":"4"}},{"id":3696333,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-15T02:55:21.000Z","date":"2019-01-14","kind":"grant","acquired":true,"shares":220000,"price":1.7,"value":374000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Option reported herein shall vest on the Vesting Start Date of January 14, 2019, and 1/24th of the remaining shares subject to the Option shall vest on each monthly anniversary of the Vesting Start Date thereafter."}],"balance_after":220000,"derivative":{"exercise_price":1.7,"expiration_date":"2029-01-14","underlying":"Common Stock","underlying_shares":220000},"source":{"system":"sec-edgar","filing":"0001415889-19-000052","document":"form4-01142019_090108.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588919000052/form4-01142019_090108.xml","form_type":"4"}},{"id":3828607,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:28:54.000Z","date":"2018-08-29","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The option vests monthly over a period of three years commencing 4/26/2017."}],"balance_after":175000,"derivative":{"exercise_price":1.5,"expiration_date":"2027-04-26","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001415889-18-001322","document":"form4-08312018_020839.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588918001322/form4-08312018_020839.xml","form_type":"4"}},{"id":3828606,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:28:54.000Z","date":"2018-08-29","kind":"disposition_to_issuer","acquired":false,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F10","text":"The reporting person agreed to cancellation of an option granted to him on 4/26/2017 in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The option vests monthly over a period of three years commencing 4/26/2017."}],"balance_after":0,"derivative":{"exercise_price":1.96,"expiration_date":"2027-04-26","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001415889-18-001322","document":"form4-08312018_020839.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588918001322/form4-08312018_020839.xml","form_type":"4"}},{"id":3828605,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:28:54.000Z","date":"2018-08-29","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option vests monthly over a period of three years commencing 11/9/2016."}],"balance_after":100000,"derivative":{"exercise_price":1.5,"expiration_date":"2026-11-09","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-18-001322","document":"form4-08312018_020839.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588918001322/form4-08312018_020839.xml","form_type":"4"}},{"id":3828604,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:28:54.000Z","date":"2018-08-29","kind":"disposition_to_issuer","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F8","text":"The reporting person agreed to cancellation of an option granted to him on 11/9/2016 in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option vests monthly over a period of three years commencing 11/9/2016."}],"balance_after":0,"derivative":{"exercise_price":3.8,"expiration_date":"2026-11-09","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-18-001322","document":"form4-08312018_020839.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588918001322/form4-08312018_020839.xml","form_type":"4"}},{"id":3828603,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:28:54.000Z","date":"2018-08-29","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option vests monthly over a period of four years commencing 6/19/2016."}],"balance_after":200000,"derivative":{"exercise_price":1.5,"expiration_date":"2026-06-19","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001415889-18-001322","document":"form4-08312018_020839.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588918001322/form4-08312018_020839.xml","form_type":"4"}},{"id":3828602,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:28:54.000Z","date":"2018-08-29","kind":"disposition_to_issuer","acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"The reporting person agreed to cancellation of an option granted to him on 6/19/2016 in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option vests monthly over a period of four years commencing 6/19/2016."}],"balance_after":0,"derivative":{"exercise_price":3.49,"expiration_date":"2026-06-19","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001415889-18-001322","document":"form4-08312018_020839.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588918001322/form4-08312018_020839.xml","form_type":"4"}},{"id":3828601,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:28:54.000Z","date":"2018-08-29","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5000,"derivative":{"exercise_price":1.5,"exercise_date":"2018-08-29","expiration_date":"2021-04-26","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001415889-18-001322","document":"form4-08312018_020839.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588918001322/form4-08312018_020839.xml","form_type":"4"}},{"id":3828600,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:28:54.000Z","date":"2018-08-29","kind":"disposition_to_issuer","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"The reporting person agreed to cancellation of an option granted to him on 4/26/2011 in exchange for a new option having a lower exercise price."}],"balance_after":0,"derivative":{"exercise_price":10,"exercise_date":"2015-04-25","expiration_date":"2021-04-26","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001415889-18-001322","document":"form4-08312018_020839.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588918001322/form4-08312018_020839.xml","form_type":"4"}},{"id":3828599,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:28:54.000Z","date":"2018-08-29","kind":"grant","acquired":true,"shares":21250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":21250,"derivative":{"exercise_price":1.5,"exercise_date":"2018-08-29","expiration_date":"2019-12-30","underlying":"Common Stock","underlying_shares":21250},"source":{"system":"sec-edgar","filing":"0001415889-18-001322","document":"form4-08312018_020839.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588918001322/form4-08312018_020839.xml","form_type":"4"}},{"id":3828598,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:28:54.000Z","date":"2018-08-29","kind":"disposition_to_issuer","acquired":false,"shares":21250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The reporting person agreed to cancellation of an option granted to him on 12/30/2009 in exchange for a new option having a lower exercise price."}],"balance_after":0,"derivative":{"exercise_price":10,"exercise_date":"2011-12-31","expiration_date":"2019-12-30","underlying":"Common Stock","underlying_shares":21250},"source":{"system":"sec-edgar","filing":"0001415889-18-001322","document":"form4-08312018_020839.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588918001322/form4-08312018_020839.xml","form_type":"4"}},{"id":3828597,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:28:54.000Z","date":"2018-08-29","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50000,"derivative":{"exercise_price":1.5,"exercise_date":"2018-08-29","expiration_date":"2019-11-04","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-18-001322","document":"form4-08312018_020839.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588918001322/form4-08312018_020839.xml","form_type":"4"}},{"id":3828596,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:28:54.000Z","date":"2018-08-29","kind":"disposition_to_issuer","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The reporting person agreed to cancellation of an option granted to him on 11/4/2009 in exchange for a new option having a lower exercise price."}],"balance_after":0,"derivative":{"exercise_price":10,"exercise_date":"2011-11-01","expiration_date":"2019-11-04","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-18-001322","document":"form4-08312018_020839.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588918001322/form4-08312018_020839.xml","form_type":"4"}},{"id":3828595,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:28:54.000Z","date":"2018-08-29","kind":"grant","acquired":true,"shares":1125,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1125,"derivative":{"exercise_price":1.5,"exercise_date":"2018-08-29","expiration_date":"2019-06-17","underlying":"Common Stock","underlying_shares":1125},"source":{"system":"sec-edgar","filing":"0001415889-18-001322","document":"form4-08312018_020839.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588918001322/form4-08312018_020839.xml","form_type":"4"}},{"id":3828594,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:28:54.000Z","date":"2018-08-29","kind":"disposition_to_issuer","acquired":false,"shares":1125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reporting person agreed to cancellation of an option granted to him on 6/17/2009 in exchange for a new option having a lower exercise price."}],"balance_after":0,"derivative":{"exercise_price":10,"exercise_date":"2009-12-17","expiration_date":"2019-06-17","underlying":"Common Stock","underlying_shares":1125},"source":{"system":"sec-edgar","filing":"0001415889-18-001322","document":"form4-08312018_020839.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588918001322/form4-08312018_020839.xml","form_type":"4"}},{"id":3828593,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:28:54.000Z","date":"2018-08-29","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3000,"derivative":{"exercise_price":1.5,"exercise_date":"2018-08-29","expiration_date":"2019-03-24","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001415889-18-001322","document":"form4-08312018_020839.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588918001322/form4-08312018_020839.xml","form_type":"4"}},{"id":3828592,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:28:54.000Z","date":"2018-08-29","kind":"disposition_to_issuer","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person agreed to cancellation of an option granted to him on 3/24/2009 in exchange for a new option having a lower exercise price."}],"balance_after":0,"derivative":{"exercise_price":10,"exercise_date":"2013-03-24","expiration_date":"2019-03-24","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001415889-18-001322","document":"form4-08312018_020839.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588918001322/form4-08312018_020839.xml","form_type":"4"}},{"id":4076123,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-05T21:55:23.000Z","date":"2018-02-02","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the Shares subject to the Option shall vest on date of grant February 2, 2018, and 1/24th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the grant date thereafter."}],"balance_after":300000,"derivative":{"exercise_price":1.16,"expiration_date":"2028-02-02","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001415889-18-000187","document":"form4-02052018_010209.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588918000187/form4-02052018_010209.xml","form_type":"4"}},{"id":4204718,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-09-20T20:33:54.000Z","date":"2017-09-19","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3rd of the total number of shares shall be immediately vested upon the Vesting Start Date, 9/19/2017, and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested two (2) years from the Vesting Start Date."}],"balance_after":125000,"derivative":{"exercise_price":1.56,"expiration_date":"2027-09-19","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001415889-17-001522","document":"form4-09202017_010944.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588917001522/form4-09202017_010944.xml","form_type":"4"}},{"id":4341995,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-04-28T19:31:35.000Z","date":"2017-04-26","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One third (1/3rd) of the total shares shall vest one (1) year following the date of grant and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested three (3) years from the date of grant."}],"balance_after":175000,"derivative":{"exercise_price":1.96,"expiration_date":"2027-04-26","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001415889-17-000679","document":"form4-04282017_120423.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588917000679/form4-04282017_120423.xml","form_type":"4"}},{"id":4560587,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":32789,"kind":"person","name":"Singh Shawn","position":1,"cik":"0001412071","reported_name":"Singh Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-11-11T01:30:24.000Z","date":"2016-11-09","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest monthly over a period of three years commencing November 9, 2016."}],"balance_after":100000,"derivative":{"exercise_price":3.8,"expiration_date":"2026-11-09","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-16-007386","document":"form4-11102016_081115.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412071/000141588916007386/form4-11102016_081115.xml","form_type":"4"}}]}